12/4/2018 | CV | Tesaro expects make-whole adjustment event for 3% convertibles
|
12/3/2018 | CV | Market Commentary: Tesaro convertibles active, up on buyout by GlaxoSmithKline; iQIYI, Liberty Media gain
|
12/3/2018 | CV | Market Commentary: Morning Commentary: Tesaro convertibles active, improve on buyout by GlaxoSmithKline
|
10/31/2018 | CV | Market Commentary: Clovis convertibles clobbered; Exact Sciences, FireEye improve; Weatherford rebounds
|
6/29/2018 | BK | Tesaro draws down $200 million tranche B loans under 2017 facility
|
6/20/2018 | CV | Market Commentary: Convertibles market eyes Redwood Trust, QTS; Intelsat in the money; Tesaro improves
|
12/6/2017 | BK | Tesaro draws down $300 million principal amount of tranche A loan
|
11/21/2017 | BKPV | Tesaro enters $500 million two-tranche term loan with BioPharma
|
8/24/2016 | CV | Market Commentary: Dycom lower outright, adds on swap; Clovis eyed for potential drug approval; REITs for sale
|
8/22/2016 | PP | Market Commentary: Biotech names eyed after Medivation takeout news; BioMarin convertibles add with shares
|
8/22/2016 | CV | Market Commentary: Biotech names eyed after Medivation takeout news; BioMarin convertibles add with shares
|
6/29/2016 | PP | Market Commentary: Tesaro surges after positive drug data; Tesla lower; Intercept Pharmaceuticals on tap
|
6/29/2016 | CV | Market Commentary: Tesaro surges after positive drug data; Tesla lower; Intercept Pharmaceuticals on tap
|
6/29/2016 | CV | Market Commentary: Morning Commentary: Tesaro surges after positive drug study data; Tesla lower; equities on the rise
|
4/7/2016 | PP | Market Commentary: Healthcare flies higher as out-of-favor sector enjoys resurgence; DepoMed, BioMarin improve
|
4/7/2016 | CV | Market Commentary: Healthcare flies higher as out-of-favor sector enjoys resurgence; DepoMed, BioMarin improve
|
2/25/2016 | PP | Tesaro plans to conduct $154.84 million private placement of stock
|
9/18/2015 | PP | Market Commentary: Convertibles quiet, steady post Fed; some health-care names better bid; Medicines edges up
|
9/18/2015 | CV | Market Commentary: Convertibles quiet, steady post Fed; some health-care names better bid; Medicines edges up
|
12/31/2014 | CV | Market Commentary: Outlook 2015: U.S. convertibles primary notches multi-year high; volume expected to climb
|
12/12/2014 | PP | Market Commentary: Non-energy-related names lower; energy marginally weaker as oil rout persists; Fiat at 102
|
12/12/2014 | CV | Market Commentary: Non-energy-related names lower; energy marginally weaker as oil rout persists; Fiat at 102
|
9/29/2014 | CV | Tesaro greenshoe exercise lifts 3% convertibles to $201.25 million
|
9/26/2014 | CV | Market Commentary: Morning Commentary: Convertibles stabilize after early weakness; Tesaro adds; Janus Capital eyed
|
9/24/2014 | PP | Market Commentary: Tesaro convertibles add outright, dollar neutral on debut; SolarCity stock up on new deal
|
9/24/2014 | CV | Market Commentary: Tesaro convertibles add outright, dollar neutral on debut; SolarCity stock up on new deal
|
9/24/2014 | CV | Market Commentary: Morning Commentary: Tesaro convertibles add on debut; SolarCity stock jumps after deal launch
|
9/24/2014 | CV | New Issue: Tesaro prices upsized $175 million seven-year convertibles to yield 3%, up 35%
|
9/23/2014 | PP | Market Commentary: Tesaro looks rich at the mids; Salix up in line or better amid M&A talk; SolarCity on tap
|
9/23/2014 | CV | Market Commentary: Tesaro looks rich at the mids; Salix up in line or better amid M&A talk; SolarCity on tap
|
9/23/2014 | CV | Market Commentary: Morning Commentary: Planned Tesaro looks rich on the mids; Salix active amid more M&A chatter
|
9/22/2014 | PP | Market Commentary: Yahoo in focus as shares drop; MGM Resorts lower in line; Tesaro on tap in registered deal
|
9/22/2014 | CV | Market Commentary: Yahoo in focus as shares drop; MGM Resorts lower in line; Tesaro on tap in registered deal
|
9/22/2014 | CV | Tesaro launches $165 million seven-year convertibles to yield 2.5%-3%, up 35%-40%
|
3/5/2013 | PP | Tesaro greenshoe exercised for $97.7 million public offering of stock
|
2/28/2013 | PP | Tesaro prices $84.96 million public offering of common stock at $18.00
|
6/28/2012 | PP | Tesaro may raise $81 million through initial public offering of stock
|